A molecule called circSLIT2 may help glioblastoma grow
Original title: METTL14/IGF2BP-mediated m6A methylation of circSLIT2 promotes malignant phenotypes of glioblastoma via the miR-127-5p/SH3GLB1 axis.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done in animals, not people. Most findings at this stage never become treatments.
This was only done in lab cells and in mice.
The short version
In lab tests, a molecule seemed to make glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary cells grow and spread faster.
What was studied. Researchers studied glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary cells grown in the lab. They looked at a molecule called circSLIT2 and how it acts inside those cells. They also tested it in mice with tumors.
What they found. glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary cells had high levels of circSLIT2. When cells made more of it, they grew, moved, and spread more. The team traced how it works, through a chain involving miR-127-5p and a protein called SH3GLB1. Mice with more circSLIT2 had larger tumors and shorter survival times.
What this means, and what it doesn't
What it could mean: Scientists have found one more piece of how glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary may grow. That gives them a possible target to aim at in future research. Nothing from this study is a treatment a patient can get.
What it doesn't mean: This is not a new treatment. The work was done in cells in a dish and in mice, not in people. No one knows yet if blocking this molecule would help a person. Most findings like this never become a drug. This is very early science, far from everyday care, and it is not a promise of a cure.
Source: PubMed, June 15, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.